Latest Loan Facility News

Reward Minerals (ASX:RWD) reported strong gold and copper assay results from its Mountain Pond Project in Newfoundland, with preparations underway for maiden drilling in the September quarter. The company also advanced its potash processing technology and ongoing discussions for the Beyondie Potash Plant in Western Australia.

Lumos Diagnostics reported a 6% revenue increase to US$13.2 million for FY26, driven by an 875% surge in FebriDx® sales following a pivotal CLIA waiver. The company expanded U.S. adoption to 170+ healthcare sites and secured milestone payments exceeding US$6 million.

West Wits Mining has achieved a major underground breakthrough at Qala Shallows, unlocking higher-grade ore zones, while completing a comprehensive ZAR 1.115 billion finance package that underpins its production ramp-up.

Electro Optic Systems (ASX:EOS) posted a 284% surge in first-half 2026 revenue to $169 million, driven by robust defence contracts and regional tensions. Its order book hit a historic $846 million, prompting an upgrade to full-year guidance and signalling strong momentum in counter-drone and laser weapon systems.

Monvia Limited, an Australian SaaS provider for life insurers, is seeking to raise $17.5 million via an IPO on the ASX. The funds will support redemption of preference shares and fuel growth in existing and new markets.

Caravel Minerals has advanced its Caravel Copper Project DFS with a 48% increase in Proven Ore Reserves and secured $15 million in new royalty funding from Regal Royalty Fund, while extending key regulatory timelines.

Papyrus Australia has tapped related party L39 Capital to lead a capital raise and secured an interest-bearing $200,000 loan from Irwin Biotech, with conversion into shares and options pending shareholder approval.

Alpha HPA Limited progresses construction of its flagship Stage 2 facility on schedule and budget, while product demand surges across semiconductor and battery sectors, with forecasts exceeding 50,000 tonnes per annum.

Paladin Energy completes Langer Heinrich Mine ramp-up, delivering strong FY2026 results and advancing its Canadian PLS Project with a new uranium discovery. FY2027 guidance forecasts stable production and costs amid ongoing regulatory progress.

Entropy Neurodynamics has reported breakthrough Phase 2 clinical results for its intravenous psilocin therapy in treatment-resistant Binge Eating Disorder, alongside strong Phase 2a data in Irritable Bowel Syndrome and a new US patent filing.

Babylon Pump & Power has initiated a $12.7 million rights issue at a 37.5% discount to restore working capital, reduce debt, and expand its water management rental fleet, aiming to lift its ASX trading suspension.

CONNEQT Health's June quarter saw record consumer revenue growth and a 70% jump in enterprise subscription ARR, supported by a $5.5 million placement and progress on its FDA regulatory pathway for its cloud-based vascular analytics platform.